Published in Semin Urol Oncol on May 01, 1999
Vitamin D metabolism and action in the prostate: implications for health and disease. Mol Cell Endocrinol (2011) 0.86
Vitamin d for the management of prostate cancer. Rev Urol (2004) 0.75
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Hypersensitivity reactions from taxol. J Clin Oncol (1990) 3.83
Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits. Neurology (2009) 2.46
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst (1994) 2.05
Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res (1988) 1.84
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol (1993) 1.76
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms. Cancer (1984) 1.71
Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol (2004) 1.70
Cutaneous involvement in malignant histiocytosis. Case report and review of the literature. Arch Dermatol (1981) 1.64
Urine based markers of urological malignancy. J Urol (2001) 1.61
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol (1993) 1.50
Clinical features and natural history of intramedullary spinal cord metastasis. Cancer (1985) 1.43
Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole. Clin Cancer Res (2000) 1.40
Transient stress lymphocytosis during crisis of sickle cell anemia and emergency trauma and medical conditions. An immunophenotyping study. Arch Pathol Lab Med (1990) 1.39
Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res (2001) 1.35
Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Blood (1991) 1.35
Behavior problems in children at time of first recognized seizure and changes over the following 3 years. Epilepsy Behav (2011) 1.27
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res (1999) 1.27
Photon correlation spectroscopy of hemoglobin: diffusion of oxy-HbA and oxy-HbS. Biopolymers (1978) 1.25
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology (1997) 1.24
Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res (1997) 1.20
Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol (1997) 1.20
Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem (2001) 1.19
Formation and alignment of Z lines in living chick myotubes microinjected with rhodamine-labeled alpha-actinin. J Cell Biol (1986) 1.19
Importance of continued testicular suppression in hormone-refractory prostate cancer. J Clin Oncol (1993) 1.18
Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer. J Urol (2000) 1.15
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol (1992) 1.15
Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res (2001) 1.15
Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism (2001) 1.15
Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest (1991) 1.15
Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep (1985) 1.15
Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res (1994) 1.13
Acquired extrinsic pulmonic stenosis caused by mediastinal tumors. Cancer (1982) 1.13
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res (1999) 1.12
Pregelation aggregation of sickle cell hemoglobin. Proc Natl Acad Sci U S A (1974) 1.11
Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma. Clin Cancer Res (2000) 1.11
Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin Cancer Res (2000) 1.10
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res (2001) 1.09
Myocardial infarction in sickle cell disease. J Natl Med Assoc (1996) 1.08
Nuclear structural proteins as biomarkers of cancer. J Cell Biochem (1999) 1.08
Factors influencing options in primary breast cancer treatment. J Clin Oncol (1987) 1.07
Sickle cell anemia: does myocardial ischemia occur during crisis? J Natl Med Assoc (1991) 1.07
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res (1993) 1.05
Hypercalcemia and neuroendocrine carcinoma of the prostate: a report of three cases and a review of the literature. J Clin Oncol (1992) 1.05
Mechanical properties of oxygenated red blood cells in sickle cell (HbSS) disease. Blood (1984) 1.04
Bromide intoxication. Johns Hopkins Med J (1976) 1.04
A phase II study of taxol in patients with malignant melanoma. Invest New Drugs (1991) 1.04
Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci (1986) 1.03
Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr (1997) 1.03
Perceived social support among depressed elderly, middle-aged, and young-adult samples: cross-sectional and longitudinal analyses. J Affect Disord (1999) 1.02
The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab (1982) 1.01
Liver involvement in sickle cell disease. Medicine (Baltimore) (1985) 1.00
Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment. Urol Clin North Am (1992) 1.00
Bone regeneration within a human segmental mandible defect: a preliminary report. Am J Otolaryngol (1995) 1.00
Cell structure and DNA organization. Crit Rev Eukaryot Gene Expr (1991) 1.00
Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Urol Oncol (2011) 0.99
A new immunocompetent murine model for oral cancer. Arch Otolaryngol Head Neck Surg (1997) 0.98
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. J Urol (2001) 0.98
The DNA-binding and tau2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal. Mol Endocrinol (1998) 0.98
Identification of eleven human hemoglobin variants by high-performance liquid chromatography: additional data on functional properties and clinical expression. Biochem Genet (1982) 0.98
Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst (1998) 0.97
Spinal cord compression in prostate cancer. J Neurooncol (1995) 0.97
Arterial blood pressure in adults with sickle cell disease. Arch Intern Med (1981) 0.97
Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemia. Br J Haematol (1989) 0.96
Academic problems in children with seizures: relationships with neuropsychological functioning and family variables during the 3 years after onset. Epilepsy Behav (2010) 0.96
A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library. Ann Surg Oncol (2000) 0.95
Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography. Am J Med (1982) 0.95
Choice of starting dose and escalation for phase I studies of antitumor agents. Cancer Chemother Pharmacol (1992) 0.94
Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer (1982) 0.94
Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors. Cancer Res (1988) 0.94
Catalysis of the disproportionation of superoxide by metalloporphyrins. III. J Inorg Biochem (1981) 0.94
Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women. N Engl J Med (1978) 0.93
Age and growth factors in porcine full-thickness wound healing. Wound Repair Regen (2002) 0.93
Effects of Host Resistance and Temperature on Development of Globodera tabacum solanacearum. J Nematol (2001) 0.93
'Sarcoidosis' and sarcoid-like lesions. Their occurrence after cytotoxic and radiation therapy of testis cancer. Arch Intern Med (1981) 0.93
Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants. Pharm Dev Technol (2000) 0.93
Metastatic Leydig cell tumor of the testis. Report of three cases and review of the literature. Cancer (1986) 0.93
Endothelium-derived relaxing factor modulates endothelin action in afferent arterioles. Hypertension (1991) 0.92
Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma. Cancer Res (1994) 0.92
Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease. Clin Sci (Lond) (1989) 0.92
Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissues. Biochem Pharmacol (1996) 0.91
Rheology of the sickle cell disorders. Baillieres Clin Haematol (1987) 0.91
Influence of oxygen tension on the viscoelastic behavior of red blood cells in sickle cell disease. Blood (1986) 0.90
Randomized study of neoadjuvant testicular androgen ablation therapy before radical prostatectomy in men with clinically localized prostate cancer. J Urol (1996) 0.90
Managing Root-knot on Tobacco in the Southeastern United States. J Nematol (1989) 0.90
Phase I study of taxol administered as a short i.v. infusion daily for 5 days. Cancer Treat Rep (1987) 0.89
Association of transcription factors with the nuclear matrix. J Cell Biochem (1996) 0.89
Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase. Clin Cancer Res (1996) 0.89